About Us Pipeline News People Careers Contact Us

 

New Targanta Appoints Garen Bohlin to Board of Directors

Targanta Study Shows Oritavancin Treatment Effective
     in a Mouse Model of Anthrax


Targanta Reports Improved Ability of Oritavancin To Stop
     Bacteria Growth In Vitro (ECCMID 2007)


Targanta Announces $70 Million Series C Financing

Targanta To Present at 9TH Annual BIO CEO and Investor
     Conference Therapeutic Workshop



Comparative Efficacy of Rifabutin and Gatifloxacin in the
     Rat Osteomyelitis Model


Efficacy of Oritavancin in a Murine Model of Bacillus
     anthracis Spore Inhalation Anthrax


Effect of Polysorbate 80 on Oritavancin Binding...

Influence of Polysorbate-80 on Susceptibility of Gram-positive
     Bacteria to Oritavancin


Efficacy of Oritavancin in a mouse model of S. pneumoniae...











































































































oritavancin oritavancin.com oritavancin.net nuvocid.com nuvocid.net MRSA osteomyelitis S. aureus S. pneumoniae